This site is intended for healthcare professionals

Go to /sign-in page

You can view 3 more pages before signing in

Management of Lipids in Practice

Posted Apr 4, 2022

Introduction

The management of dyslipidaemia has become a particularly important component of the treatment of cardiovascular disease such as coronary artery disease and stroke. These conditions are generally managed in primary care under the supervision of both GP and practice nurse and are a large component of the GMS contract. This resource composed of 10 assessment questions, tests your knowledge of commonly encountered problems relating to the management and diagnosis of lipid disorders typical of clinical practice. Complete the questions and download your CPD certificate to add to your portfolio. You should record the time spent on this resource.

Aims and Objectives

After successful completion of this resource, the user should be able to:

  • Understand the role of dyslipidaemia in the generation of cardiovascular and cerebrovascular disease.
  • Understand the approaches to the management of lipid disorders with specific therapies.
  • Understand the contribution of various lipid fractions to cardiovascular disease and its treatment.

Contents

  1. 1.
  2. 2.
  3. 3.

Introduction

The management of dyslipidaemia has become a particularly important component of the treatment of cardiovascular disease such as coronary artery disease and stroke. These conditions are generally managed in primary care under the supervision of both GP and practice nurse and are a large component of the GMS contract. This resource composed of 10 assessment questions, tests your knowledge of commonly encountered problems relating to the management and diagnosis of lipid disorders typical of clinical practice. Complete the questions and gain 1hr of continuous professional development to add to your personal development portfolio.

Aims and Objectives

After successful completion of this resource, the user should have

  • A better understanding of the role of dyslipidaemia in the generation of cardiovascular and cerebrovascular disease.
  • An improved understanding of the approaches to the management of lipid disorders with specific therapies.
  • An improved knowledge of the contribution of various lipid fractions to cardiovascular disease and its treatment.

Online Reading list:

Lipid management

NICE Guidance CG67

NICE guidance on familial hypercholesterolaemia

Related modules

View all Modules

  • title

    label
  • title

    label
  • title

    label
  • title

    label
  • title

    label
  • title

    label